Medications for Melanoma

10 results

  • braftovi - encorafenib capsule

    (Encorafenib)
    Array Biopharma Inc.
    Braftovi treats unresectable or metastatic melanoma (BRAF V600E/V600K), metastatic colorectal cancer (BRAF V600E), and metastatic non-small cell lung cancer (BRAF V600E) in adults. Used in combination with binimetinib or cetuximab. Requires FDA-authorized BRAF mutation testing.
    Medication Details
    Drug Interactions

  • imlygic - talimogene laherparepvec injection, suspension

    (Talimogene Laherparepvec)
    Amgen Inc
    IMLYGIC is an oncolytic viral therapy for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in melanoma patients who have had a recurrence after initial surgery. It has not been shown to improve overall survival or affect visceral metastases.
    Medication Details
    Drug Interactions

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions

  • mektovi - binimetinib tablet, film coated

    (Binimetinib)
    Array Biopharma Inc.
    Mektovi (binimetinib) is used with encorafenib to treat unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as confirmed by an FDA-approved test.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • opdivo - nivolumab injection

    (Nivolumab)
    E.R. Squibb & Sons, L.L.C.
    Opdivo is a PD-1 blocking antibody indicated for multiple cancers including melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal cancer, and gastric cancers in adults and select pediatric patients.
    Medication Details
    Drug Interactions

  • tecentriq - atezolizumab injection, solution

    (Atezolizumab)
    Genentech, Inc.
    Tecentriq is a PD-L1 blocking antibody indicated for non-small cell lung cancer (adjuvant and metastatic), extensive-stage small cell lung cancer, unresectable or metastatic hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and alveolar soft part sarcoma in adults and pediatric patients 2 years and older.
    Medication Details
    Drug Interactions

  • yervoy - ipilimumab injection

    (Ipilimumab)
    E.R. Squibb & Sons, L.L.C.
    Yervoy treats multiple advanced cancers in adults and pediatric patients (12+), including melanoma, renal cell carcinoma, MSI-H colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, and esophageal squamous cell carcinoma—primarily in combination with nivolumab.
    Medication Details
    Drug Interactions